State of Wyoming’s Ascendis Pharma A/S ASND Stock Holding History

State of Wyoming’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$320K	Sell	1,200 -10	-0.8%	-$2.34K	0.03%	670
2026 Q1	$277K	Buy	1,210 +390	+48%	+$87.4K	0.03%	718
2025 Q4	$175K	Buy	+820	New	+$169K	0.02%	1065
2025 Q3	–	Sell	-70	Closed	-$12.1K	–	1838
2025 Q2	$12.1K	Buy	+70	New	+$11.4K	﹤0.01%	1750
2022 Q3	–	Sell	-446	Closed	-$41K	–	1535
2022 Q2	$41K	Buy	446 +153	+52%	+$14.4K	0.03%	1058
2022 Q1	$34K	Sell	293 -64	-18%	-$7.41K	0.02%	1249
2021 Q4	$48K	Buy	357 +54	+18%	+$8.03K	0.02%	1122
2021 Q3	$48K	Sell	303 -189	-38%	-$25.9K	0.03%	767
2021 Q2	$65K	Buy	492 +289	+142%	+$38.5K	0.04%	634
2021 Q1	$26K	Buy	+203	New	+$30.9K	0.04%	287

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State of Wyoming's ASND Position: Q2 2026 in Review

State of Wyoming reduced its Ascendis Pharma A/S (ASND) stake by 0.83% in Q2 2026, selling an estimated $2.34K and leaving 1,200 shares worth $320K. The position accounts for 0.03% of the portfolio, ranked #670.

State of Wyoming first reported a position in ASND in Q1 2021 and has held it in 10 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

State of Wyoming held 1,200 shares of Ascendis Pharma A/S worth $320K as of Q2 2026.
State of Wyoming sold 10 Ascendis Pharma A/S shares in Q2 2026, an estimated $2.34K.
Ascendis Pharma A/S made up 0.03% of State of Wyoming's portfolio in Q2 2026, its #670 holding.
State of Wyoming first reported a position in Ascendis Pharma A/S in Q1 2021 and has held it in 10 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.